Clinical Trial

Late-term Abortions Between 14 and 16 Weeks of Gestation: Comparison of Hemorrhagic Risks in Surgical vs. Medical Abortions

Study acronym: IVG-Tardives
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Since the extension of the legal abortion limit to 16 weeks by the law of March 2, 2022, we must adapt our care to reduce the risks associated with this procedure. According to the French National Authority for Health (HAS), all abortions after 9 weeks of gestation should be performed surgically, but the French National College of Gynecologists and Obstetricians (CNGOF) indicates that each patient should have the choice of method regardless of the gestational age at the time of the abortion.
Trial Details
NCT Number NCT07335939
Lead Sponsor University Hospital, Strasbourg, France
Conditions Abortion Late
Enrollment 50 participants
Start Date 2025-05-19
Primary Completion 2026-06 (estimated)
Study Completion 2026-06-19 (estimated)
Updated on ClinicalTrials.gov 2026-01-13